Table 3. Most common adverse events*.
Adverse event | Any grade | Grade 3 or 4 | ||
---|---|---|---|---|
N | % | n | % | |
Alopecia | 38 | 95 | - | - |
Anxiety | 6 | 15 | - | - |
Bone pain | 6 | 15 | - | - |
Constipation | 9 | 23 | - | - |
Deranged transaminases | 2 | 5 | 2 | 5 |
Diarrhoea | 8 | 20 | 1 | 2 |
Dysgeusia | 6 | 15 | - | - |
Dyspepsia | 4 | 10 | - | - |
Fatigue | 27 | 68 | 1 | 2 |
Febrile neutropenia | 3 | 8 | 3 | 8 |
Gastro-oesophageal reflux | 8 | 20 | - | - |
Headache | 6 | 15 | - | - |
Insomnia | 7 | 18 | - | - |
Nausea | 25 | 63 | - | - |
Neutropenia | 23 | 58 | 7 | 18 |
Sensory neuropathy | 22 | 55 | 2 | 5 |
Pneumothorax | 1 | 2 | 1 | 2 |
* Any grade reported for at least 10% of patients or grade ≥3 using CTCAE Version 4.0 reported for any patient. If a patient had more than one adverse event within a preferred term, the patient was counted once in the term.